KR100421203B1 - Herb medicine composition to be spreaded on sanitary napkin for female - Google Patents

Herb medicine composition to be spreaded on sanitary napkin for female Download PDF

Info

Publication number
KR100421203B1
KR100421203B1 KR10-2000-0025731A KR20000025731A KR100421203B1 KR 100421203 B1 KR100421203 B1 KR 100421203B1 KR 20000025731 A KR20000025731 A KR 20000025731A KR 100421203 B1 KR100421203 B1 KR 100421203B1
Authority
KR
South Korea
Prior art keywords
composition
sanitary napkin
women
present
odor
Prior art date
Application number
KR10-2000-0025731A
Other languages
Korean (ko)
Other versions
KR20010014909A (en
Inventor
안득훈
백인진
안태훈
이은정
Original Assignee
(주)순한방
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)순한방 filed Critical (주)순한방
Priority to KR10-2000-0025731A priority Critical patent/KR100421203B1/en
Publication of KR20010014909A publication Critical patent/KR20010014909A/en
Application granted granted Critical
Publication of KR100421203B1 publication Critical patent/KR100421203B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

본 발명은 오배자를 포함하는 여성용 생리대 도포용 조성물에 관한 것이다. 바람직하게는 애엽, 고삼, 황백, 사상자 및 백반으로 구성되는 군으로부터 선택된 1종 이상의 생약을 더 포함하는 여성용 생리대 도포용 조성물에 관한 것이다.The present invention relates to a composition for applying a sanitary napkin for women comprising a gall bladder. Preferably, the present invention relates to a composition for applying a sanitary napkin for women, which further comprises at least one herbal medicine selected from the group consisting of young leaf, red ginseng, yellow white, casualty and alum.

본 발명의 조성물은 이를 여성용 생리대에 적용시켜 사용하였을 때 여성의 생리시 발생하는 취기와 소양감을 억제해 준다.The composition of the present invention suppresses the odor and pruritus generated during women's menstruation when it is applied to a women's sanitary napkin.

Description

생약제를 이용한 여성용 생리대 도포용 조성물 {Herb medicine composition to be spreaded on sanitary napkin for female}Herbal medicine composition to be spreaded on sanitary napkin for female}

본 발명은 여성용 생리대 도포용 조성물에 관한 것으로서 보다 구체적으로는 여성의 생리시 발생하는 취기와 소양감을 제거하기 위하여 여성용 생리대에 도포할 수 있는 생약추출성분을 함유하는 여성용 생리대 도포용 조성물에 관한 것이다.The present invention relates to a composition for applying a woman's sanitary napkin, and more particularly, to a composition for applying a woman's sanitary napkin containing a herbal extract component that can be applied to a woman's sanitary napkin in order to remove odor and pruritus generated during women's menstruation.

여성의 생리량은 각 개인에 따라 많은 차이가 있으나 보통 100~300 cc정도로써 이중 순수한 혈액의 양은 30~50 cc정도이며 경관점액이나 외음피지선등 여러 가지 분비물과 융해된 내막 등이 혼합되어 있고 이 분비물로 인하여 건강한 여성도 생리시 독특한 취기가 있게 된다.Women's physiology varies greatly from person to person, but is usually about 100 to 300 cc, of which the blood volume is about 30 to 50 cc, which is mixed with various secretions such as cervical mucus and vulvovaginal glands and fused inner lining. Due to healthy women will have a unique odor during menstruation.

현재까지 많이 사용되고 있는 여성용 생리대는 생리량의 많고 적음에 따라 그 크기나 두께를 달리하여 생리혈을 흡수하여 주는 단순기능의 패드로써 이는 여성의 생리때마다 발생되는 독특한 취기와 소양감을 제거하지는 못하였다.대부분의 여성용 생리대는 바깥쪽이 비닐로 덮여있어 수분이 새지 않는 구조이며 이것은 마치 욕실창을 막아둔 상태와도 같아서 당연히 곰팡이나 세균이 번식하기 쉬운 것이다. 여성이 초경이후 폐경이 될 때까지 수십년 동안 격게되는 생리혈 특유의 취기는 여성의 활동을 위축시키는 주요한 원인이 되어왔다.Women's sanitary napkins, which are widely used to date, are simple pads that absorb menstrual blood by varying their size or thickness according to the amount of the menstrual volume, which does not remove the unique odor and pruritus that occur every time menstruation. Women's Sanitary Napkin is covered with vinyl on the outside to prevent moisture from leaking. It's like a bathroom window, so it's easy for mold and bacteria to grow. Menstrual blood odor, which has been plunging for decades from the time menopause until menopause, has been a major contributor to women's activity.

본 발명자 등은 여성의 생리시 발생되는 취기와 소양감을 제거하기 위하여 많은 연구 끝에 약물이 도포된 면포나 종이시트를 이용하여 패드화하면 생리혈이 통과하면서 약물과 혼합되고 그 혼합된 약물효과로 인하여 취기와 소양감을 방지할 수 있다는 것을 발견하여 본 발명을 완성하였다.In order to remove the odor and pruritus generated during women's menstruation, the present inventors have padded the cotton pad or paper sheet coated with the drug after many studies and mixed with the drug as the menstrual blood passes and the odor due to the mixed drug effect. The present invention was found to be able to prevent pruritus with.

따라서 본 발명의 목적은 인체에 무해한 생약을 이용하여 피부접촉면의 소양감과 생리혈의 취기 자체를 근본적으로 방지한 여성용 생리대 도포용 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a composition for applying a sanitary napkin for women, which prevents the prism of the skin contact surface and the odor of menstrual blood by using a herbal medicine harmless to the human body.

도 1은 본 발명의 조성물을 적용한 여성용 생리대의 예로서 적용예 6의 단면도이다. 여기에서 a와 c는 폴리프로필렌 막, b는 1차 패드, d는 흡수용 매트릭스, 그리고 e는 비닐카바이다.1 is a cross-sectional view of Application Example 6 as an example of a sanitary napkin for women to which the composition of the present invention is applied. Where a and c are polypropylene membranes, b is the primary pad, d is the absorption matrix, and e is the vinyl cover.

본 발명은 오배자를 포함하는 여성용 생리대 도포용 조성물에 관한 것이다.The present invention relates to a composition for applying a sanitary napkin for women comprising a gall bladder.

상세하게는, 본 발명은 여성의 생리시 발생되는 취기를 방지하기 위하여 여성용 생리대에 적용시킬 수 있는 생약 조성물로서, 항균 및 방부의 효과가 있는 오배자를 주성분으로서 포함하는 여성용 생리대 도포용 조성물에 관한 것이다.In detail, the present invention relates to a composition for applying a sanitary napkin for women as a herbal composition that can be applied to a women's sanitary napkin in order to prevent odor generated during menstruation, comprising as a main component of the antimicrobial and antiseptic effect. .

대한 약전과 기존 한의서에 수록된 바에 따르면 오배자는, 70%의 탄닌질과 전분을 함유하고 있어 수렴성질이 강한 생약으로 세포분비를 억제하여 점막을 건조하게 하므로 지사, 지혈, 대하, 구강염 등에 이용되며 외용으로 부인의 자궁출혈과 여성기 질환에 분말을 도포하거나 전탕하여 사용된다. 또한 함유된 탄닌은 단백을 침전 응고시켜 세균의 영양과 대사에 영향을 주어 항균과 방부의 효과가 있으며 알칼로이드 등의 중독 해독제로 사용된다.According to the Korean Pharmacopoeia and the traditional Chinese medicine book, the gall bladder contains 70% of tannin and starch, which is a strong astringent drug, which suppresses cell secretion and makes the mucous membrane dry, so it is used for branch, hemostasis, lobulation, oralitis. It is used to apply or apply powder to uterine bleeding and female disease. In addition, the tannins contained in the protein precipitate and coagulate, affecting the nutrition and metabolism of bacteria, which has antibacterial and antiseptic effects, and is used as an antidote for alkaloids.

본 발명의 조성물은 오배자 단독으로 함유하여도 본 발명의 목적을 충분히 달성할 수 있으나, 애엽, 고삼, 황백, 사상자 및 백반으로 구성되는 군으로부터 선택된 1종 이상의 생약을 더 포함하는 것이 보다 바람직하며 이때, 각 성분들은 조성물 총 건조중량에 대하여 오배자는 25~98중량%, 애엽은 2~30중량%, 고삼은 2~30중량%, 황백은 10~50중량%, 사상자는 1~20중량% 및 백반은 10~40중량%의 조성으로 포함된다. 여기에서 더욱 더 바람직하게는 오배자와 함께 애엽, 황백, 사상자 및 백반을 포함하거나, 오배자와 함께 고삼, 황백, 사상자 및 백반을 포함하는 것이다.The composition of the present invention can fully achieve the object of the present invention, even if contained alone in the gall, but more preferably comprises at least one herb selected from the group consisting of apple leaf, red ginseng, yellow white, casualty and alum. , Each component is 25 to 98% by weight, 2 to 30% by weight, 2-30% by weight of red ginseng, 10 to 50% by weight of yellow ginseng, 1 to 20% by weight of yellow and white, Alum is included in the composition of 10 to 40% by weight. Even more preferably it is to include a leaf lobe, yellow white, casualty and alum with the gallant, or to include ginseng, yellow white, casualty and alum with the gallant.

대한 약전과 기존 한의서에 수록된 바에 따르면 애엽은, 월경불순, 대하 등 부인과 질환에 다용되는 생약으로서 임균 등에 항균작용이 있고 외용으로는 습진 및 피부, 소양 등에 전탕하여 사용된다.According to the Korean Pharmacopoeia and the traditional Chinese medicine book, Aeopyeop is a herbal medicine that is widely used in gynecological diseases such as menstrual irregularities and crayfish.

또한, 고삼은 그 맛이 너무 쓰기 때문에 주로 외용으로 이용되는데, 항 트리코모나스 작용이 있어서 가려움이 심한 피부질환과 습진, 피부화농증 등 임상에서주로 습포요법이나 세정제로 사용된다.In addition, ginseng is used for external use because its taste is too much, it is used in the clinical treatment, such as skin disease, eczema, dermatitis, severe itching due to anti- trichomonas action is mainly used as a poultice therapy or cleaning agent.

또한, 황백은 대장균, 티푸스균 및 콜레라균에 대하여 살균력이 있으며 그람양성, 그람음성균, 임균에 강한 항균작용을 가지고 있다. 황백의 성분중 베르베린은 국소 수렴작용이 강하여 소양성 피부질환에 주로 외용하여 상처 부위의 열독을 해독하는 효능이 있다.In addition, yellow and white bacterium has bactericidal activity against E. coli, typhoid bacteria and cholera bacteria, and has a strong antimicrobial effect against Gram-positive, Gram-negative, and gonococcus bacteria. Berberine, a component of yellowish white, has a strong local astringent action, so it is mainly used for pruritic skin diseases and has the effect of detoxifying heat poisoning at wound sites.

또한, 사상자는 조습 및 살충의 효능이 있어 외용으로 여성의 음부소양증에 분말 혹은 전탕하여 세척제로 다용되는 약제이다.In addition, the casualty is a drug that has a potency of moisturizing and insecticidal, so that it can be used as a cleaning agent by powdering or frying to female pruritus for external use.

또한, 백반은 수렴작용과 항균 및 지양의 효능이 강하여 염증부의 불쾌감과 악취를 제거하여 청량감을 주므로 주로 외용으로 피부점막의 염증 수렴제나 국소 수렴의 목적으로 함수용으로 사용된다.In addition, alum has a strong astringent action and antimicrobial and Jiyang effect, removes the discomfort and odor of the inflammatory area to give a refreshing feeling is mainly used for the purpose of the external astringent inflammatory convergence or topical convergence of the skin mucosa.

상기한 생약제들 즉 오배자, 애엽, 고삼, 황백, 사상자 및 백반은 모두 인체에 무해하면서도 항균 및 소양효과로 인해 임상에서 빈용되는 약제로 항균과 수렴 성분이 강하며 방부의 효능으로 인하여 생리시의 취기와 소양감을 신속히 없애줄 뿐만 아니라 생약특유의 찬 성질로 말미암아 생리시 여성기의 습한감을 방지할 수 있는 것이다.The above-mentioned herbal medicines, ie, gall bladder, larvae, ginseng, yellowish white, casualty and alum, are all harmless to humans due to their antibacterial and pruritic effects and are often used in clinical practice. Not only does it quickly get rid of pruritus, but also the cold nature of herbal medicines prevents the dampness of the female period during menstruation.

오배자, 애엽, 고삼, 황백, 사상자 및 백반은 각각 분말, 추출액 및 침출액 중 선택된 어느 한 형태로서 여성용 생리대 도포용 조성물을 구성할 수 있다. 예를 들면 상기 생약들을 물로 유효성분을 추출하여 백반 침출여액과 혼합하여 사용할 수 있다.The gall bladder, larvae, red ginseng, yellowish white, filamentous and alum are constituents for the application of women's sanitary napkins as any one selected from powder, extract and leaching solution, respectively. For example, the herbal medicines can be used in combination with the alum leaching filtrate by extracting the active ingredient with water.

본 발명의 조성물에는 그 약효 성분의 물리 화학적 성질에 따라 약제학적으로 허용되는 담체를 함유시켜 산제, 액제, 현탁제 또는 겔제형태로 만들어 사용할 수 있으며 또한 본 발명의 조성물은 기타의 첨가제를 추가로 함유할 수 있다. 본 발명의 조성물은 그 용도의 관점에서 볼 때 액제 제형이 특히 바람직하나 필요에 따라 산제, 분무제, 분산제, 겔제 등의 다른 제형으로 바꾸어 패드를 구성할 수도 있다.The composition of the present invention may be used in the form of a powder, a liquid, a suspension or a gel by containing a pharmaceutically acceptable carrier according to the physicochemical properties of the active ingredient, and the composition of the present invention further contains other additives. can do. The composition of the present invention is particularly preferred in terms of its use in terms of liquid formulation, but may be replaced with other formulations such as powders, sprays, dispersants, gels, etc., if necessary, to form the pads.

본 발명의 또 다른 태양은 본 발명의 조성물을 적용시킨 여성용 생리대이다. 본 발명의 조성물은 생리대의 흡수용 매트릭스 전체에 골고루 함유시켜 적용할 수도 있으나 이때 흡수용 매트릭스 자체의 흡수성이 저하되는 문제가 있으므로 매트릭스 자체에는 흡수시키지 않고 다만 매트릭스의 상층 표면 즉 생리혈이 매트릭스로 흡수되어 들어갈때 통과해야 하는 표면에만 도포시켜 생리혈이 본 발명의 조성물과 섞이면서 매트릭스에 흡수되어 들어 가도록 하는 것이 바람직하다. 그 하나의 예로서 본 발명의 조성물을 면포나 종이시트 등에 충분히 도포시킨 1차 패드를 기존의 생리대에 얹어서 사용하는 방법이 있다.Another aspect of the invention is a feminine sanitary napkin to which the composition of the invention is applied. The composition of the present invention may be applied evenly contained throughout the absorption matrix of the sanitary napkin, but at this time, there is a problem that the absorbency of the absorption matrix itself is lowered, so that the upper surface of the matrix, that is, menstrual blood is absorbed into the matrix. It is desirable to apply only to the surface that must pass through to allow physiological blood to be absorbed into the matrix while mixing with the composition of the present invention. As one example, there is a method in which a primary pad obtained by sufficiently applying the composition of the present invention to a cotton cloth or a paper sheet or the like is placed on an existing sanitary napkin.

본 발명의 조성물을 적용하는 또 다른 방법으로는 예를 들어 조성물을 산제로하여 생리대 전체에 골고루 포함시켜 흡수용 매트릭스 자체의 흡수성에는 영향을 주지 않고 다만 생리혈이 본 발명의 조성물과 잘 섞일 수 있도록 하는 방법이 있다.In another method of applying the composition of the present invention, for example, as a powder as a composition to be uniformly included throughout the sanitary napkin so as not to affect the absorbency of the absorption matrix itself so that menstrual blood can be mixed well with the composition of the present invention. There is a way.

본 발명의 조성물은 흡수용 매트릭스 자체의 흡수성을 저하시키지 않는 한 생리혈이 본 발명의 조성물과 잘 섞일 수 있는 방법이라면 어떤 것으로라도 적용할수 있다.The composition of the present invention can be applied to any method as long as it can mix well with the composition of the present invention so long as the absorbency of the absorption matrix itself is not lowered.

본 발명은 이하의 실시예 및 실험예를 들어 더욱 구체적으로 설명되나 이들 실시예가 본 발명의 범위를 제한하는 것은 아니다.The present invention will be described in more detail with reference to the following examples and experimental examples, but these examples do not limit the scope of the present invention.

실시예 1. 여성용 생리대 도포용 조성물의 제조Example 1.Preparation of the composition for the application of women's sanitary napkin

오배자 800 g을 증류수로 세척한 후 5000 ml 들이 원형 플라스크에 넣고 증류수 2000 ml를 가하여 냉각기를 부착하고 2시간 동안 가열 추출하였다. 추출액을 여과포로 여과하여 이 여액을 감압농축시켜 점조성 추출물 1000 ml를 수득하였다.After gall bladder 800 g was washed with distilled water, 5000 ml round flask was added and 2000 ml of distilled water was added to the cooler, followed by heat extraction for 2 hours. The extract was filtered through a filter cloth, and the filtrate was concentrated under reduced pressure to obtain 1000 ml of viscous extract.

실시예 2. 여성용 생리대 도포용 조성물의 제조Example 2 Preparation of Composition for Applying Women's Sanitary Napkin

오배자 600 g을 증류수로 세척한 후 백반 200 g과 함께 5000 ml 들이 원형 플라스크에 넣고 증류수 2000 ml를 가하여 냉각기를 부착하고 2시간 동안 가열 추출하였다. 추출액을 여과포로 여과하여 이 여액을 감압농축시켜 점조성 추출물 1000 ml를 수득하였다.After gall bladder 600 g was washed with distilled water, and 200 g of alum were added to a 5000 ml round flask, 2000 ml of distilled water was added thereto, and a cooler was attached and heated and extracted for 2 hours. The extract was filtered through a filter cloth, and the filtrate was concentrated under reduced pressure to obtain 1000 ml of viscous extract.

실시예 3. 여성용 생리대 도포용 조성물의 제조Example 3 Preparation of Composition for Applying Women's Sanitary Napkin

오배자 760 g과 애엽 40 g을 증류수로 세척한 후 5000 ml 들이 원형 플라스크에 넣고 증류수 2000 ml를 가하여 냉각기를 부착하고 2시간 동안 가열 추출하였다. 추출액을 여과포로 여과하여 이 여액을 감압농축시켜 점조성 추출물 1000 ml를수득하였다.760 g of gall bladder and 40 g of young leaf were washed with distilled water, and 5000 ml of round flasks were added to 2000 ml of distilled water, and a cooler was attached and heated and extracted for 2 hours. The extract was filtered with a filter cloth, and the filtrate was concentrated under reduced pressure to obtain 1000 ml of viscous extract.

실시예 4. 여성용 생리대 도포용 조성물의 제조Example 4 Preparation of Composition for Applying Women's Sanitary Napkin

오배자 640 g과 황백 160 g을 증류수로 세척한 후 5000 ml 들이 원형 플라스크에 넣고 증류수 2000 ml를 가하여 냉각기를 부착하고 2시간 동안 가열 추출하였다. 추출액을 여과포로 여과하여 이 여액을 감압농축시켜 점조성 추출물 1000 ml를 수득하였다.After 640 g of gall and 160 g of sulfur white were washed with distilled water, 5000 ml were placed in a round flask, 2000 ml of distilled water was added thereto, and a cooler was attached and heated and extracted for 2 hours. The extract was filtered through a filter cloth, and the filtrate was concentrated under reduced pressure to obtain 1000 ml of viscous extract.

실시예 5. 여성용 생리대 도포용 조성물의 제조Example 5 Preparation of Composition for Applying Women's Sanitary Napkin

가) 오배자 300 g, 고삼 100 g, 황백 150 g, 사상자 50 g 및 백반 100 g을 증류수로 세척한 후 5000 ml 들이 원형 플라스크에 넣고 증류수 2000 ml를 가하여 냉각기를 부착하고 2시간 동안 가열 추출하였다. 추출액을 여과포로 여과하여 이 여액을 감압농축시켜 점조성 추출물 500 ml를 수득하였다.A) Five ginseng 300 g, 100 g of red ginseng, 150 g of yellow white, 50 g of white filament and 100 g of alum were washed with distilled water, and 5000 ml of round flask was added to 2000 ml of distilled water to attach a cooler, followed by heat extraction for 2 hours. The extract was filtered through a filter cloth, and the filtrate was concentrated under reduced pressure to obtain 500 ml of a viscous extract.

나) 백반 100 g을 분쇄하여 정제수 500 m1에 75~80℃ 의 온도에서 2시간 동안 온침한 후 여과하여 가)에서 수득한 점조성 추출액과 1:1의 비율로 혼합하여 원액을 제조하였다.B) 100 g of alum was pulverized and warmed in 500 m1 of purified water at a temperature of 75 to 80 ° C. for 2 hours, followed by filtration to mix the viscous extract obtained in a) in a ratio of 1: 1 to prepare a stock solution.

실시예 6. 여성용 생리대 도포용 조성물의 제조Example 6 Preparation of Composition for Applying Women's Sanitary Napkin

가) 오배자 30 ㎏, 애엽 10 ㎏, 황백 24 ㎏, 사상자 2 ㎏ 및 백반 5 ㎏ 을 증류수로 세척한 후 스팀을 이용한 가열용 2중탱크로된 용기에 정제수 1200 ℓ를함께 넣고 95~100℃에서 8시간 가열한 후 수득한 추출물을 1차 여과하였다. 그 여과액을 2중 탱크의 저장조로 옮긴 다음 다시 2차 여과필터를 거쳐 60℃에서 감압 농축시켜 점조성 추출물 40ℓ를 수득하였다.A) 5 g of gallocytes, 10 kg of loaves, 24 kg of yellowish white, 2 kg of casualties and 5 kg of alum and distilled water, and then put 1200 L of purified water together in a double tank for heating using steam at 95 ~ 100 ℃. After heating for 8 hours, the obtained extract was first filtered. The filtrate was transferred to a storage tank of a double tank, and then concentrated under reduced pressure at 60 ° C. through a secondary filtration filter to obtain 40 L of a viscous extract.

나) 백반 5 ㎏을 분쇄하여 정제수 40 ℓ에 75~80℃ 의 온도에서 2시간 동안 온침한 후 여과하여 가)에서 수득한 점조성 추출액과 1:1의 비율로 혼합하여 원액을 제조하였다.B) 5 kg of alum was ground and immersed in 40 L of purified water at a temperature of 75 to 80 ° C. for 2 hours, and then filtered and mixed with the viscous extract obtained in A) in a ratio of 1: 1 to prepare a stock solution.

적용예 1~5. 1차 패드의 제조Application example 1-5. Preparation of Primary Pads

가로 14cm 세로 5cm의 천연펄프로 만든 냅프킨 티슈을 상기 실시예 1~5에서 제조한 조성물에 각각 담그어 티슈 1장당 조성물이 건조중량으로서 0.25 g이 균일하게 도포되도록 하였다.이를 건조시켜 1차 패드를 제조하였다.Napkin tissues made of natural pulp of 14 cm width and 5 cm width were immersed in the compositions prepared in Examples 1 to 5, respectively, so that 0.25 g of the composition per dry tissue was uniformly applied as a dry weight. It was.

적용예 6~10. 샘플 패드의 제조Application example 6-10. Preparation of Sample Pads

상기 적용예 1~5에서 제조한 1차 패드를 각각 기저귀 제조용 100% 폴리프로필렌 2겹 사이에 넣고 순간 열처리로 접착시켰다. 이를 기존에 쓰던 생리대에 올려 도 1과 같은 형태가 되도록 하였다.The primary pads prepared in Application Examples 1 to 5 were respectively sandwiched between two layers of 100% polypropylene for diaper production and bonded by instant heat treatment. This was put on a sanitary napkin that was previously used to be in the form as shown in FIG.

적용예 11. 생리대의 제조Application Example 11. Preparation of Sanitary Napkin

폭 12 cm, 길이 4000 m의 여성용 생리대에 사용되는 부직포에 상기 실시예 6에서 제조한 조성물을 도포하여 가로 21 ㎝, 세로 9 ㎝의 패드 1장당 조성물을 건조중량으로서 약 1 g이 균일하게 도포되도록 하였다. 이 도포된 부직포를 이용하여 분쇄용 펄프와 흡수체를 함께 투입하여 현재 여성용 생리대를 생산하고 있는 공장에서 가로 21 ㎝, 세로 9 ㎝의 생리대를 제조하였다.The composition prepared in Example 6 was applied to a nonwoven fabric used in a women's sanitary napkin having a width of 12 cm and a length of 4000 m so that approximately 1 g of the composition per pad of 21 cm width and 9 cm length was uniformly applied as a dry weight. It was. Using this coated nonwoven fabric, a pulp for grinding and an absorbent were put together to produce a sanitary napkin having a width of 21 cm and a length of 9 cm in a factory currently producing women's sanitary napkins.

실험예 1. 독성 및 부작용 확인 실험 IExperimental Example 1. Toxicity and Side Effects Confirmation Experiment I

상기 실시예 5에서 제조한 조성물을 성장한 암컷 토끼 4마리의 질구에 3 ml씩 20분 간격으로 5회 도포한 다음 6시간 동안 매 시간 마다 성기의 상태를 관찰하였고 또 조성물 6 ml씩을 5일간 연속해서 도포하여 관찰하였다.The composition prepared in Example 5 was applied to the vaginal openings of four female rabbits three times at 20 minute intervals of 3 ml each, and then the state of the genitals was observed every 6 hours for 6 hours. It was applied and observed.

그 결과 본 발명의 조성물 도포로 인한 질구의 수축 이외에는 성기 표피의 변질이나 어떠한 조직학적 변화도 관찰되지 않았다.As a result, no alteration of the genital epidermis or any histological change was observed except vaginal contraction due to application of the composition of the present invention.

실험예 2. 독성 및 부작용 확인 실험 ⅡExperimental Example 2. Toxicity and Side Effects Confirmation Experiment Ⅱ

상기 적용예 10에서 제조한 샘플 패드를 본 발명자들의 가족 중 2명을 선택하여 3개월 동안 기존에 쓰던 생리대에 부착하여 피부접촉면의 반응을 관찰하도록 하였다.The sample pads prepared in Application Example 10 were selected from two members of the present inventors and attached to a sanitary napkin that was used for three months to observe the skin contact surface reaction.

그 결과 본 발명의 조성물이 도포된 패드 사용에 따른 어떠한 피부조직의 변화나 국소적 부작용이 관찰되지 않았다. 그런데 생리혈이 패드에 흡수되고 난 뒤에는 그 색이 검은빛으로 변하는 것을 관찰할 수 있었는데 이는 생리혈이 흡수될 때 패드에 도포된 약물과 혼합되어 일어난 현상으로서 분비물과 약물이 함께 섞여 있는 상태이므로 본 발명의 목적인 취기 억제와 소양감 방지에 주요한 작용기전으로추정되었다.As a result, no changes in skin tissue or local side effects were observed with the use of the pad to which the composition of the present invention was applied. However, after the menstrual blood was absorbed by the pad, the color was changed to black. This phenomenon occurred when the menstrual blood was absorbed and mixed with the drug applied to the pad, and the secretion and the drug were mixed together. It is estimated to be the major mechanism of action for suppressing odor and preventing pruritus.

실험예 3. 생리혈의 취기 및 소양감에 대한 효능실험Experimental Example 3. Efficacy test on odor and pruritus of menstrual blood

상기 실시예 1, 2 및 5에 조성물을 적용시킨 적용예 6, 7 및 10에서 제조한 샘플 패드를 각각 이용하여 효능실험을 하였다. 실험대상은 본 효능 실험에 동의한 여성들은 모두 평소 취기와 나름대로의 소양감을 가지고 있었고 특별한 기질적인 신체 이상은 없었다. 샘플 패드는 실험 대상자 1인당 하루 평균 5장을 소비한다고 보고 6일분의 패드량을 나누어 주었다. 그 결과를 각자의 생리가 끝남과 동시에 보고하도록 하였다. 실험에 참가한 전원이 약 한달 후 그 결과를 보고하였으며 결과는 다음 표 1~6과 같았다.Efficacy experiments were carried out using the sample pads prepared in Application Examples 6, 7 and 10 to which the compositions were applied to Examples 1, 2 and 5, respectively. Subjects were all women who agreed with the efficacy test, and had a peculiar feeling of odor. The sample pads consumed an average of 5 sheets per person per day, and divided the pad amount for 6 days. The results were reported at the end of each period. All the participants participated in the experiment reported the result after about a month, and the results were shown in the following Tables 1-6.

적용예 6의 실험결과Experimental Result of Application Example 6 연령age 피험자수Number of subjects 취기 억제효과를 인정한 피험자수Number of subjects who recognized odor suppression effect 효과없음no effect 30% 억제30% Suppression 50% 억제50% Suppression 70%억제70% Suppression 90% 억제90% Suppression 10대10 22 00 00 1One 1One 00 20대20's 66 00 1One 33 1One 1One 30대30 spaces 44 00 1One 1One 22 00 40대40 spaces 22 00 1One 1One 00 00 합계(총인원에대한 백분율)Total (percentage of total people) 1414 00 3 (21.4%)3 (21.4%) 6 (42.9%)6 (42.9%) 4 (28.6%)4 (28.6%) 1 (7.1%)1 (7.1%)

적용예 6의 실험결과Experimental Result of Application Example 6 연령age 피험자수Number of subjects 소양감 억제효과를 인정한 피험자수Number of subjects who recognized pruritus inhibitory effect 효과없음no effect 30% 억제30% Suppression 50% 억제50% Suppression 70%억제70% Suppression 90% 억제90% Suppression 10대10 22 00 00 22 00 00 20대20's 66 00 22 44 00 00 30대30 spaces 44 00 1One 22 1One 00 40대40 spaces 22 00 00 22 00 00 합계(총인원에대한 백분율)Total (percentage of total people) 1414 00 3 (21.4%)3 (21.4%) 10 (71.4%)10 (71.4%) 1 (7.1%)1 (7.1%) 00

적용예 7의 실험결과Experimental Results of Application Example 7 연령age 피험자수Number of subjects 취기 억제효과를 인정한 피험자수Number of subjects who recognized odor suppression effect 효과없음no effect 30% 억제30% Suppression 50% 억제50% Suppression 70%억제70% Suppression 90% 억제90% Suppression 10대10 22 00 00 00 22 00 20대20's 1010 00 1One 33 55 1One 30대30 spaces 66 00 00 1One 44 1One 40대40 spaces 22 00 00 1One 1One 00 합계(총인원에대한 백분율)Total (percentage of total people) 2020 00 1 (5.0%)1 (5.0%) 5 (25.0%)5 (25.0%) 12 (60.0%)12 (60.0%) 2 (10.0%)2 (10.0%)

적용예 7의 실험결과Experimental Results of Application Example 7 연령age 피험자수Number of subjects 소양감 억제효과를 인정한 피험자수Number of subjects who recognized pruritus inhibitory effect 효과없음no effect 30% 억제30% Suppression 50% 억제50% Suppression 70%억제70% Suppression 90% 억제90% Suppression 10대10 22 00 00 00 1One 1One 20대20's 1010 00 1One 33 66 00 30대30 spaces 66 00 00 22 22 22 40대40 spaces 22 00 00 1One 1One 00 합계(총인원에대한 백분율)Total (percentage of total people) 2020 00 1 (5.0%)1 (5.0%) 6 (30.0%)6 (30.0%) 10 (50.0%)10 (50.0%) 3 (15.0%)3 (15.0%)

적용예 10의 실험결과Experimental Result of Application Example 10 연령age 피험자수Number of subjects 취기 억제효과를 인정한 피험자수Number of subjects who recognized odor suppression effect 효과없음no effect 30% 억제30% Suppression 50% 억제50% Suppression 70%억제70% Suppression 90% 억제90% Suppression 10대10 1One 00 00 1One 00 00 20대20's 88 00 00 1One 55 22 30대30 spaces 22 00 00 00 1One 1One 40대40 spaces 1One 00 00 1One 00 00 합계(총인원에대한 백분율)Total (percentage of total people) 1212 00 00 3 (25.0%)3 (25.0%) 6 (50.0%)6 (50.0%) 3 (25.0%)3 (25.0%)

적용예 10의 실험결과Experimental Result of Application Example 10 연령age 피험자수Number of subjects 소양감 억제효과를 인정한 피험자수Number of subjects who recognized pruritus inhibitory effect 효과없음no effect 30% 억제30% Suppression 50% 억제50% Suppression 70%억제70% Suppression 90% 억제90% Suppression 10대10 1One 00 00 00 00 1One 20대20's 88 00 22 33 22 1One 30대30 spaces 22 00 00 22 00 00 40대40 spaces 1One 00 00 00 1One 00 합계(총인원에대한 백분율)Total (percentage of total people) 1212 00 2 (16.7%)2 (16.7%) 5 (41.7%)5 (41.7%) 3 (25.0%)3 (25.0%) 2 (16.7%)2 (16.7%)

실시예 1의 조성물을 적용한 적용예 6에 대한 실험결과, 표 1의 취기 억제 효과 및 표 2의 소양감 억제효과 모두, 전 피험자의 78.6%가 50% 이상의 억제효과가 있는 것으로 보고하였다.Experimental results for the application example 6 to which the composition of Example 1 was applied, 78.6% of all subjects were reported to have an inhibitory effect of 50% or more in both the odor inhibitory effect of Table 1 and the anti-pruritic effect of Table 2.

실시예 2의 조성물을 적용한 적용예 7에 대한 실험결과는, 표 3의 취기 억제 효과 및 표 2의 소양감 억제효과 모두, 전 피험자의 95.0%가 50% 이상의 억제효과가 있는 것으로 보고하였다.Experimental results for the application example 7 applying the composition of Example 2, 95.0% of all subjects reported that the odor inhibitory effect of Table 3 and the pruritus inhibitory effect of Table 2 has an inhibitory effect of 50% or more.

또한 실시예 5의 조성물을 적용한 적용예 10에 대한 실험결과에서는, 표 5의 취기 억제 효과는 모든 피험자 전원이 50% 이상 취기가 억제되는 것으로 보고하였으며 특히 취기를 거의 느끼지 못한 (90% 이상의 취기억제 효과를 보고한) 피 시험자도 3명(25.0%)이나 되었다. 또한 표 6의 소양감 억제효과 역시 전 피험자의 83.3%가 50% 이상의 억제효과가 있는 것으로 보고하였다.In addition, in the experimental results for the application example 10 to which the composition of Example 5 is applied, the odor inhibitory effect of Table 5 reported that all the subjects are odor suppressed by more than 50%, especially seldom felt odor (90% or more odor suppression) Three (25.0%) of the subjects reported the effect. In addition, the antipruritic effect of Table 6 also reported that 83.3% of all subjects had an inhibitory effect of 50% or more.

피험자 모두 생리혈의 변화 외에는 본 패드 착용 후 어떠한 부작용도 관찰되지 않았다.None of the subjects observed any adverse effects after wearing the pad except for changes in menstrual blood.

실험예 4. 생리혈의 취기 및 소양감 억제효과에 대한 비교실험Experimental Example 4. Comparative experiment on the effects of physiological blood odor and pruritus

현재 시중에 유통 판매되고 있는 여성용 생리대 중 취기억제 효과가 있다고 광고되고 있는 두 가지 제품 (A사 제품 및 B사 제품)과 본 발명의 조성물을 적용한 생리대의 취기억제 효능에 대한 비교실험을 실시하였다.A comparative experiment was conducted on the efficacy of the odor inhibitors of the sanitary napkins to which the composition of the present invention was applied and the two products (products of A company and B company) advertised as odor inhibitors among women's sanitary napkins currently on the market.

본 발명의 조성물을 적용한 생리대로서는 실시예 6의 조성물을 적용한 적용예 11의 여성용 생리대를 이용하였다. 실험대상은 본 비교실험에 동의한 여성 중 총 20명을 무작위로 선택하였고 실험 방법은 생리대 효능에 관한 조사항목을 설정하고 미리 설문지를 작성하여 실험 대상자들에게 조사 항목에 대하여 주지시킨 후 1인당 각각의 생리대 10장씩 총 30장씩을 나누어 주었다. 조사 항목은 1) 취기 억제효과, 2) 소양감 억제효과 및 3) 기타 패드착용 후 의견 란으로 구성하였고 그결과를 각자의 생리가 끝남과 동시에 보고하도록 하였다.As the sanitary napkin to which the composition of the present invention was applied, the female sanitary napkin of Application Example 11 to which the composition of Example 6 was applied was used. Subjects were the total number of women Twenty people were randomly selected and the test method was to set up a survey item about sanitary napkin efficacy, fill out a questionnaire in advance, inform the subjects about the survey item, and divide 10 total sanitary napkins for each person. The survey items consisted of 1) odor suppression effect, 2) anti-pruritic effect, and 3) other opinions after wearing pads.

본 실험 결과 응답자 전원이 A사 제품 및 B사 제품의 취기 억제효과가 전혀 없거나 (응답자의 90%) 미미하다 (응답자의 10%)는 반응을 확인할 수 있었으나 이와는 대조적으로 본 발명의 조성물을 적용한 생리대의 취기 억제효과는 응답자 전원에게서 명확한 취기 억제효과 뿐만아니라 명확한 소양감 억제효과까지 있음을 확인할 수 있었다.As a result of this experiment, all respondents showed no or no odor suppression effect (90% of respondents) or insignificant (10% of respondents) of company A and company B, but in contrast, the sanitary napkin to which the composition of the present invention was applied It was confirmed that the odor suppression effect of all respondents had not only a clear odor suppression effect but also a clear anti-pruritic effect.

실험예 5. 생리혈의 취기 및 소양감 억제효과에 대한 일반 소비자 실험Experimental Example 5. General Consumer Experiments on the Inhibitory Effects of Menstrual Blood Odor and Pruritus

대한민국 서울과 청주 및 대구지역에 거주하는 생리 가능한 13세에서 49세까지의 여성중 60명을 무작위로 선정하여 본 발명의 조성물을 적용한 생리대를 착용시키고 그 효능을 실험하였다. 본 발명의 조성물을 적용한 생리대로서는 실시예 6의 조성물을 적용한 적용예 11의 여성용 생리대를 이용하였다.We randomly selected 60 women from 13 to 49 years of age who live in Seoul, Cheongju, and Daegu, Korea, and wore a sanitary napkin to which the composition of the present invention was applied. As the sanitary napkin to which the composition of the present invention was applied, the female sanitary napkin of Application Example 11 to which the composition of Example 6 was applied was used.

전 피험자 중 95%이상의 피험자가 취기 억제효과가 우수 (70%이상의 억제효과 있음)하거나 효과가 있다 (25%이상의 억제효과 있음)고 응답을 하였다. 소양감 억제효과는 기존에 소양감을 느끼지 못한 15%의 여성을 제외하면 거의 100%의 여성이 소양감 억제효과가 탁월 (전 피험자 중 67%의 응답)하거나 효과가 있다(전 피험자 중 18%의 응답)고 응답하였다.More than 95% of the subjects responded that they had excellent odor suppression (more than 70%) or were effective (more than 25%). The antipruritic effect is almost 100% of women with excellent anti-pruritic effect (67% of all subjects) or effective (except 18% of all subjects), except for 15% of women who did not feel it. Replied.

또한 본 발명의 조성물을 적용한 생리대를 착용한 결과 대다수의 여성에게서 생리혈이 옆으로 퍼져 흐르는 현상이 없고 피부 접촉면의 습한감을 느끼지 못했다는 사실을 확인할 수 있었으며 특히 병적인 생리(하혈)로 인하여 한달 내내 생리대를 착용하는 여성의 경우 냄새는 물론이고 피부 짓무름의 고통에서 벗어날 수 있었다는 사실을 확인할 수 있었다. 이는 본 발명의 생약 특유의 성질 즉 조습과 수렴의 성질에 기인한 것으로서 본 발명의 조성물이 가지는 취기 억제 및 소양감 억제효과 외에도 또 하나의 중요한 장점이 된다.In addition, as a result of wearing the sanitary napkin to which the composition of the present invention was applied, it was confirmed that the majority of women had no menstrual blood flowing sideways and did not feel the wetness of the skin contact surface. For women wearing the smell as well as the skin was found to have been able to escape the pain of soreness. This is due to the peculiar nature of the herbal medicine of the present invention, namely, moisture and convergence, which is another important advantage in addition to the odor suppression and pruritus suppression effect of the composition of the present invention.

또한 실제 소비자 실험 결과에서도 피험자 모두 피부 접촉면의 어떠한 부작용도 관찰되지 않았다.In addition, all the subjects did not observe any adverse effects on the skin contact surface in actual consumer test results.

인체에 무해하면서 특히 치료 효과를 나타내는 천연 약물을 이용하여 제조한 본 발명의 조성물을 도포한 여성용 생리대는, 기존의 생리대가 해결치 못했던, 생리시 발생되는 피부접촉면의 소양감과 생리혈의 취기 자체를 흡수와 동시에 억제하여 주므로 취기로 인한 활동의 위축을 막고, 여성의 보다 능동적인 생활을 기대할 수 있으며 취기로부터 근본적으로 여성을 해방시킬 수 있다. 또한 본 발명의 조성물은 현재 여성용 생리대에 사용되고 있는 기존의 부직포 등에도 바로 도포하여 적용시킬 수 있으므로 산업적 이용가치도 매우 높다.Women's sanitary napkin coated with the composition of the present invention prepared using a natural drug that is harmless to the human body and exhibits a therapeutic effect, in particular, absorbs the pruritus of the skin contact surface and the odor of menstrual blood generated during menstruation, which conventional sanitary napkins have not solved. At the same time, it prevents the decline of activities caused by odors, expects a more active life of women, and fundamentally liberates women from odors. In addition, the composition of the present invention can be applied directly to the existing non-woven fabrics that are currently used in women's sanitary napkins, so the industrial use value is also very high.

Claims (6)

오배자 25~77중량%, 애엽 2~30중량%, 황백 10~50중량%, 사상자 1~20중량%, 및 백반 10~40중량%를 포함하는 여성용 생리대 도포용 조성물.A composition for applying a female sanitary napkin comprising 25 to 77% by weight, 2 to 30% by weight of young leaves, 10 to 50% by weight of yellow and white, 1 to 20% by weight of casualties, and 10 to 40% by weight of alum. 오배자 25~77중량%, 고삼 2~30중량%, 황백 10~50중량%, 사상자 1~20중량%, 및 백반 10~40중량%를 포함하는 여성용 생리대 도포용 조성물.A female sanitary napkin coating composition comprising 25 to 77% by weight, 2 to 30% by weight, red ginseng, 10 to 50% by weight, 1 to 20% by weight of casualties, and 10 to 40% by weight of alum. 삭제delete 삭제delete 삭제delete 삭제delete
KR10-2000-0025731A 1999-07-13 2000-05-15 Herb medicine composition to be spreaded on sanitary napkin for female KR100421203B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0025731A KR100421203B1 (en) 1999-07-13 2000-05-15 Herb medicine composition to be spreaded on sanitary napkin for female

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19990028248 1999-07-13
KR1019990028248 1999-07-13
KR10-2000-0025731A KR100421203B1 (en) 1999-07-13 2000-05-15 Herb medicine composition to be spreaded on sanitary napkin for female

Publications (2)

Publication Number Publication Date
KR20010014909A KR20010014909A (en) 2001-02-26
KR100421203B1 true KR100421203B1 (en) 2004-03-02

Family

ID=26635812

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0025731A KR100421203B1 (en) 1999-07-13 2000-05-15 Herb medicine composition to be spreaded on sanitary napkin for female

Country Status (1)

Country Link
KR (1) KR100421203B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030034280A (en) * 2001-09-25 2003-05-09 주식회사 바이오랜드 Antibiotic composition for a sanitary napkin
KR20030048646A (en) * 2001-12-12 2003-06-25 구미이화공업 주식회사 Wet tissue containing herb medicine extract for woman and method for preparing same
KR100619146B1 (en) 2005-01-04 2006-09-01 씨제이 주식회사 Compositions for sterilizing spores of spore-forming microorganisms comprising the extracts of torilidis fructus
KR100894411B1 (en) * 2007-07-23 2009-04-24 웅진코웨이주식회사 Herb medicine antibacterial coatings and the herb medicine antibacterial filter coated with the same
CN111818887B (en) * 2019-03-06 2022-12-20 尤妮佳股份有限公司 Absorbent article

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960009979A (en) * 1994-09-30 1996-04-20 서영헌 Manufacturing method of herbal pad
KR19980082895A (en) * 1997-05-09 1998-12-05 성재갑 sanitary pad
KR19990011833A (en) * 1997-07-25 1999-02-18 김이현 Pharmaceutical composition for the treatment of gynecological diseases and women's obesity and preparation method of the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960009979A (en) * 1994-09-30 1996-04-20 서영헌 Manufacturing method of herbal pad
KR19980082895A (en) * 1997-05-09 1998-12-05 성재갑 sanitary pad
KR19990011833A (en) * 1997-07-25 1999-02-18 김이현 Pharmaceutical composition for the treatment of gynecological diseases and women's obesity and preparation method of the same

Also Published As

Publication number Publication date
KR20010014909A (en) 2001-02-26

Similar Documents

Publication Publication Date Title
KR101345709B1 (en) Antibacterial and antifungal composition and Ladies genital area cleanser composition comprising antibacterial and antifungal composition for preventing and treating vaginitis
JP2019517533A (en) External pharmaceutical composition for treatment of various wound wounds of skin and preparation method thereof
KR20050088063A (en) A hygienic band and manufacturing method include chinese herb medicine a composite
US7166307B1 (en) Herb medicine composition to be spread on sanitary napkin for female
KR100661014B1 (en) Herb extract-containing composition for sanitary napkin
CN103316262A (en) Gynecological external antibacterial liquid and preparation method thereof
US6995297B1 (en) Herb medicine composition to be contained in sanitary materials for infants
WO2007126186A1 (en) Woman's panties contains bioceramic materials for alleviating menstrual pains and menstrual syndrom
KR20020062474A (en) Composition of herbs having curing effects for vaginitis and lecorrhea, and hygienic pad manufactured using the Composition
KR100421203B1 (en) Herb medicine composition to be spreaded on sanitary napkin for female
CN109481724A (en) A kind of antibacterial warms up palace and dispels peculiar smell super-absorbent sanitary napkin and preparation method thereof
KR100387420B1 (en) Disposable hygienic napkin treated with oriental medicine
CN111658564A (en) Gynecological vulva foam lotion and preparation method thereof
KR100420059B1 (en) Multi-functional mensturual pad contained bioceramic substances and method thereof
CN104306841A (en) Traditional Chinese medicine lotion for curing gynecologic inflammation, scytitis and pruritus
CN106943618B (en) A kind of wormwood health sanitary napkin and preparation method thereof
KR100353287B1 (en) Diper comprising herb medicine composition
KR100769304B1 (en) Herb medicine composition to be contained in wet paper for infants
KR20090030905A (en) Disposable absorbent articles comprising functional materials
CN110801056A (en) A female physiological health underpants with effects of eliminating odor, promoting blood circulation, resisting bacteria and diminishing inflammation
CN108403520A (en) A kind of chitosan Mrs Chinese herbal medicine conditioning liquid and its application
CN107754001A (en) A kind of feminine care non-woven fabrics for preventing and treating puerperal infection and its application
KR101465843B1 (en) Natural dye toilet papers for curing a hemorrhoids and the method of manufacturing thereof
KR100563573B1 (en) Health pad for men and women
CN114470048A (en) External lotion and preparation method and application thereof

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J206 Request for trial to confirm the scope of a patent right
J204 Request for invalidation trial [patent]
J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20040918

Effective date: 20050728

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20040917

Effective date: 20050728

Free format text: TRIAL NUMBER: 2004100002034; TRIAL DECISION FOR INVALIDATION REQUESTED 20040918

Effective date: 20050728

Free format text: TRIAL NUMBER: 2004100002027; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20040917

Effective date: 20050728

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

Free format text: TRIAL NUMBER: 2005200007590; INVALIDATION

J122 Written withdrawal of action (patent court)
FPAY Annual fee payment

Payment date: 20100222

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee